LONDON, June 20, 2016 /PRNewswire/ --
Building on the trusted reputation of MOVICOL® over the last 20 years.
Demonstrating Norgine's expertise in gastroenterology with the development and commercialisation of innovative products.
Norgine B.V. today announced the launch of MOVICOL® Ready to Take in Germany. In Germany it is called MOVICOL® trinkfertig. MOVICOL® Ready to Take is used for the treatment of acute and chronic constipation in adults, adolescents and the elderly.
MOVICOL® Ready to Take is a ready mixed, pocket size dose that can be taken anywhere, at any time. It is an extension to the product line of the well-established MOVICOL® brand which has been available for over 20 years in Europe and Australia/New Zealand via Norgine's infrastructure and in the rest of world through a network of partners.
Peter Martin, COO at Norgine said: "The launch of MOVICOL® Ready to Take in Germany reinforces Norgine's ability to develop and commercialise products that offer value to healthcare professionals, health systems and more importantly that meet patients' needs."
He added: "The first launch of the new MOVICOL® Ready to Take is significant for Norgine, as it builds on MOVICOL®'s leading position, but it also continues to demonstrate Norgine's gastroenterology expertise and capabilities as a European specialist pharma company."
Norgine anticipates launching MOVICOL® Ready to Take through its European infrastructure later on this year.
To view full release go to http://www.norgine.com
1. MOVICOL Ready To Take. Instructions For Use. September 2015.
Isabelle Jouin, T: +44 (0)1895 453643
Charlotte Andrews, T: +44 (0)1895 453607
Follow us @norgine
SOURCE Norgine B.V.